Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
732.5 GBX | -1.68% | -0.75% | -7.41% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 18 | DiscoverIE set to meet full-year expectations; maintains momentum | AN |
Valuation
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 289 | 435.5 | 599.4 | 746.8 | 742.3 | 713.4 | - | - |
Enterprise Value (EV) 1 | 352.3 | 496.8 | 646.6 | 777 | 785 | 818.4 | 803.2 | 792.3 |
P/E ratio | 20.3 x | 29.8 x | 51.5 x | 30 x | 35.5 x | 35.2 x | 31.7 x | 27.6 x |
Yield | 2.42% | 0.6% | 1.51% | 1.37% | 1.49% | 1.61% | 1.69% | 1.8% |
Capitalization / Revenue | 0.66 x | 0.93 x | 1.32 x | 1.97 x | 1.65 x | 1.62 x | 1.55 x | 1.49 x |
EV / Revenue | 0.8 x | 1.07 x | 1.42 x | 2.05 x | 1.75 x | 1.86 x | 1.74 x | 1.65 x |
EV / EBITDA | 9.52 x | 9.82 x | 13.4 x | 14.4 x | 11.8 x | 11.8 x | 10.8 x | 10.2 x |
EV / FCF | 20.5 x | 15.9 x | 15.1 x | 31.5 x | 16.9 x | 28 x | 25.9 x | 23.4 x |
FCF Yield | 4.88% | 6.3% | 6.6% | 3.18% | 5.92% | 3.57% | 3.86% | 4.28% |
Price to Book | 2.21 x | 2.13 x | 2.96 x | 2.6 x | 2.45 x | 2.33 x | 2.24 x | 2.14 x |
Nbr of stocks (in thousands) | 73,361 | 88,706 | 89,456 | 94,767 | 96,275 | 95,760 | - | - |
Reference price 2 | 3.940 | 4.910 | 6.700 | 7.880 | 7.710 | 7.450 | 7.450 | 7.450 |
Announcement Date | 6/4/19 | 6/24/20 | 6/3/21 | 6/14/22 | 6/7/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 438.9 | 466.4 | 454.3 | 379.2 | 448.9 | 439.4 | 461.5 | 480 |
EBITDA 1 | 37 | 50.6 | 48.4 | 53.9 | 66.4 | 69.29 | 74.72 | 77.84 |
EBIT 1 | 30.6 | 37.1 | 35.2 | 41.4 | 51.8 | 56.7 | 61.64 | 64.73 |
Operating Margin | 6.97% | 7.95% | 7.75% | 10.92% | 11.54% | 12.9% | 13.36% | 13.49% |
Earnings before Tax (EBT) 1 | 19.3 | 19.5 | 17 | 17.1 | 29.1 | 28.65 | 33.14 | 37.88 |
Net income 1 | 14.6 | 14.3 | 12 | 25.2 | 21.3 | 20.65 | 21.82 | 25.79 |
Net margin | 3.33% | 3.07% | 2.64% | 6.65% | 4.74% | 4.7% | 4.73% | 5.37% |
EPS 2 | 0.1940 | 0.1650 | 0.1300 | 0.2630 | 0.2170 | 0.2115 | 0.2350 | 0.2700 |
Free Cash Flow 1 | 17.2 | 31.3 | 42.7 | 24.7 | 46.5 | 29.24 | 31.04 | 33.88 |
FCF margin | 3.92% | 6.71% | 9.4% | 6.51% | 10.36% | 6.65% | 6.73% | 7.06% |
FCF Conversion (EBITDA) | 46.49% | 61.86% | 88.22% | 45.83% | 70.03% | 42.21% | 41.55% | 43.53% |
FCF Conversion (Net income) | 117.81% | 218.88% | 355.83% | 98.02% | 218.31% | 141.59% | 142.24% | 131.41% |
Dividend per Share 2 | 0.0955 | 0.0297 | 0.1015 | 0.1080 | 0.1145 | 0.1200 | 0.1262 | 0.1338 |
Announcement Date | 6/4/19 | 6/24/20 | 6/3/21 | 6/14/22 | 6/7/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: Maart | 2021 S1 | 2023 S1 | 2024 S1 | 2024 S2 |
---|---|---|---|---|
Net sales | - | - | - | - |
EBITDA | - | - | - | - |
EBIT 1 | - | 25.6 | - | 27.7 |
Operating Margin | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - |
Net income | 10.4 | - | 11.5 | - |
Net margin | - | - | - | - |
EPS | 0.0580 | - | 0.1170 | - |
Dividend per Share | - | - | - | - |
Announcement Date | 11/30/20 | 11/23/22 | 12/5/23 | - |
Balance Sheet Analysis
Fiscal Period: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 63.3 | 61.3 | 47.2 | 30.2 | 42.7 | 105 | 89.8 | 78.9 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.711 x | 1.211 x | 0.9752 x | 0.5603 x | 0.6431 x | 1.515 x | 1.202 x | 1.014 x |
Free Cash Flow 1 | 17.2 | 31.3 | 42.7 | 24.7 | 46.5 | 29.2 | 31 | 33.9 |
ROE (net income / shareholders' equity) | 15.5% | 16% | 11.7% | 11.3% | 11.6% | 10.4% | 11% | 11.4% |
ROA (Net income/ Total Assets) | - | - | - | - | - | 3.81% | 4.71% | 5.29% |
Assets 1 | - | - | - | - | - | 542 | 463.7 | 487.5 |
Book Value Per Share 2 | 1.790 | 2.310 | 2.260 | 3.030 | 3.150 | 3.200 | 3.320 | 3.470 |
Cash Flow per Share 2 | 0.3200 | 0.5100 | 0.4900 | 0.6100 | 0.6000 | 0.4400 | 0.4700 | 0.5100 |
Capex 1 | 5.2 | 6.3 | 3.9 | 6.2 | 5.6 | 8.37 | 9.03 | 9.71 |
Capex / Sales | 1.18% | 1.35% | 0.86% | 1.64% | 1.25% | 1.91% | 1.96% | 2.02% |
Announcement Date | 6/4/19 | 6/24/20 | 6/3/21 | 6/14/22 | 6/7/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.41% | 904M | |
+32.93% | 79.11B | |
+64.11% | 73.92B | |
-4.44% | 34.26B | |
-7.81% | 31.58B | |
-9.40% | 13.91B | |
-7.26% | 10.62B | |
+11.21% | 10.05B | |
-7.65% | 9.78B | |
+34.00% | 8.89B |
- Stock Market
- Equities
- DSCV Stock
- Financials discoverIE Group plc